Biotech company BridgeBio Pharma has announced that Sixth Street and HealthCare Royalty, a royalty acquisition company, majority owned by KKR, will provide a combined $1 billion of financing to the California-based company. This investment provides the company with a major capital injection at a key point in its growth story. The deal is significant as […] The post BridgeBio raises $1 billion in financing, signaling strong market growth appeared…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.